Glutamate receptors in human caudate nucleus in normal aging and Alzheimer's disease

Current Alzheimer Research

Volumn 10, Issue 5, 2013, Pages 469-475

  Tsamis, Konstantinos I ^a   Mytilinaios, Dimitrios G ^a,b   Njau, Samuel N ^a   Baloyannis, Stavros J ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Dementia; GluR2; mGluR5; Neostriatum; Neurotransmission; NMDAR1

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 5; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CELL SIZE; CONNECTOME; FEMALE; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; CAUDATE NUCLEUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; POSTMORTEM CHANGES; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; UP-REGULATION; YOUNG ADULT;

EID: 84888225420     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011310050002     Document Type: Article

References (41)

1. Smeal RM, Keefe KA, Wilcox KS. Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum. Eur J Neurosci 28(10): 2041-2052 (2008).
2. Kemp JM, Powell TP. The site of termination of afferent fibres in the caudate nucleus. Philos Trans R Soc Lond B Biol Sci 262(845): 413-427 (1971).
3. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organization of the basal ganglia. J Anat 196(Pt 4): 527-542 (2000).
4. Deng YP, Shelby E, Reiner AJ. Immunohistochemical localization of AMPA-type glutamate receptor subunits in the striatum of rhesus monkey. Brain Res 1344: 104-123 (2010).
5. Kuppenbender KD, Standaert DG, Feuerstein TJ, Penney JB, Jr., Young AB, Landwehrmeyer GB. Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J Comp Neurol 419(4): 407-421 (2000).
6. Testa CM, Standaert DG, Young AB, Penney JB, Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14(5 Pt 2): 3005-3018 (1994).
7. Seger CA, Cincotta CM. Dynamics of frontal, striatal, and hippocampal systems during rule learning. Cereb Cortex 16(11): 1546-1555 (2006).
8. Graybiel AM. Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 5(6): 733-741 (1995).
9. Roberts RC, Roche JK, Conley RR. Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis. Synapse 56(4): 185-197 (2005).
10. Looi JC, Lindberg O, Zandbelt BB, Ostberg P, Andersen C, Botes L, et al. Caudate nucleus volumes in frontotemporal lobar degeneration: differential atrophy in subtypes. AJNR Am J Neuroradiol 29(8): 1537-1543 (2008).
11. Guimaraes HC, Levy R, Teixeira AL, Beato RG, Caramelli P. Neurobiology of apathy in Alzheimer's disease. Arq Neuropsiquiatr 66(2B): 436-443 (2008).
12. Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, et al. Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology 43(2): 93-102 (2011).
13. Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. J Neural Transm Suppl 54: 77-95 (1998).
14. Kokubo H, Kayed R, Glabe CG, Yamaguchi H. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res 1031(2): 222-228 (2005).
15. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4): 572-580 (1991).
16. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 138(1): 235-246 (1991).
17. Oyanagi K, Takahashi H, Wakabayashi K, Ikuta F. Large neurons in the neostriatum in Alzheimer's disease and progressive supranuclear palsy: a topographic, histologic and ultrastructural investigation. Brain Res 544(2): 221-226 (1991).
18. Braak H, Braak E. Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49(3): 215-224 (1990).
19. Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 131(Pt 9): 2455-2463 (2008).
20. Ferrarini L, Palm WM, Olofsen H, van Buchem MA, Reiber JH, Admiraal-Behloul F. Shape differences of the brain ventricles in Alzheimer's disease. Neuroimage 32(3): 1060-1069 (2006).
21. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210(1): 7-13 (2008).
22. Testa CM, Standaert DG, Landwehrmeyer GB, Penney JB, Jr., Young AB. Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons. J Comp Neurol 354(2): 241-252 (1995).
23. Bernard V, Bolam JP. Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur J Neurosci 10(12): 3721-3736 (1998).
24. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4): 239-259 (1991).
25. Zhao T, Liu X, Zhen X, Guo SW. Levo-tetrahydropalmatine retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci 18(1): 28-45 (2011).
26. Ma L, Ostrovsky H, Miles G, Lipski J, Funk GD, Nicholson LF. Differential expression of group I metabotropic glutamate receptors in human motoneurons at low and high risk of degeneration in amyotrophic lateral sclerosis. Neuroscience 143(1): 95-104 (2006).
27. Liu SJ, Gasperini R, Foa L, Small DH. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J Alzheimers Dis 21(2): 655-666 (2010).
28. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 41(11): 1599-1604 (1993).
29. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32(6): 1216-1223 (2007).
30. Meng SZ, Obonai T, Isumi H, Takashima S. A developmental expression of AMPA-selective glutamate receptor subunits in human basal ganglia. Brain Dev 19(6): 388-392 (1997).
31. Selden N, Geula C, Hersh L, Mesulam MM. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience 60(3): 621-636 (1994).
32. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18(12): 527-535 (1995).
33. Oka A, Takashima S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol 97(3): 275-278 (1999).
34. Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, et al. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 66(5): 739-754 (2010).
35. Tsai VW, Scott HL, Lewis RJ, Dodd PR. The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Neurotox Res 7(1-2): 125-141 (2005).
36. Popkirov SG, Manahan-Vaughan D. Involvement of the metabotropic glutamate receptor mGluR5 in NMDA receptor-dependent, learning-facilitated long-term depression in CA1 synapses. Cereb Cortex 21(3): 501-509 (2011).
37. Anwyl R. Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56(4): 735-740 (2009).
38. Pizzi M, Sarnico I, Boroni F, Benarese M, Steimberg N, Mazzoleni G, et al. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ 12(7): 761-772 (2005).
39. Cleva RM, Olive MF. Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules 16(3): 2097-2106 (2011).
40. Fowler SW, Ramsey AK, Walker JM, Serfozo P, Olive MF, Schachtman TR, et al. Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats. Neurobiol Learn Mem 95(1): 73-79 (2011).
41. Veloz MF, Buijsen R, Willemsen R, Cupido A, Bosman LW, Koekkoek SK, et al. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice. Genes Brain Behav (2012).